Advocacy intelligence hub — real-time data for patient organizations
AstraZeneca — PHASE1, PHASE2
Maria Fountoulaki — NA
SOTIO Biotech AG — PHASE1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences — PHASE2
BriaCell Therapeutics Corporation — PHASE3
Bioxodes S.A. — PHASE2
Biocad — PHASE3
Shanghai Chest Hospital — PHASE1, PHASE2
Biocad — PHASE3
GI Innovation, Inc. — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs